Markets
H.C. Wainwright Reiterates Buy on Caribou Biosciences: What Traders Need to Know
H.C. Wainwright has reiterated its Buy rating on Caribou Biosciences, keeping the spotlight on one of biotech's most closely watched cell therapy developers. Here's why the call matters and what the charts say right now.